-
Europe Facing ‘Uphill Battle' With Covid Vaccines as Italy Blocks AstraZeneca Shipment
Europe’s coronavirus vaccine rollout has been thrust into the spotlight again after Italy blocked a shipment of Oxford-AstraZeneca vaccines to Australia.
-
Italy Blocks Shipment of AstraZeneca Covid Vaccine Destined for Australia
The European Commission, the institution leading the purchase agreements, has been blamed for not securing enough vaccines.
-
Emergent BioSolutions Says It Can Make 1 Billion COVID Vaccine Doses Annually
Emergent CEO Bob Kramer told CNBC that the company has infrastructure in place to produce Johnson & Johnson and AstraZeneca vaccines around the clock.
-
Real-World Data Shows Pfizer's Covid Vaccine Is Giving ‘Very Strong' Results After One Dose
Figures in a research paper from Public Health England showed how vaccines can significantly reduce hospitalizations in the elderly.
-
4 Charts Show How the UK's Coronavirus Vaccine Rollout Is Starting to Work
The first real-world data from the U.K.’s inoculation program has given an insight into how effective vaccines have been against Covid-19.
-
Pressured European Officials Are Trying to Drum Up Support for the AstraZeneca Covid Vaccine
European officials are coming under increasing pressure to reverse restrictions on who can receive the AstraZeneca Covid vaccine.
-
What to Watch Today: Stocks to Start New Month Higher After Late-February Selloff
U.S. stock futures started the new month moving sharply higher Monday, trying to put a dent in the late February decline.
-
Stocks Making the Biggest Moves in the Premarket: Hilton Grand Vacations, J&J, NRG Energy & More
The stocks making the biggest moves in premarket trading include Hilton Grand Vacations, J&J, NRG Energy, and more.
-
European Leaders Double Down on Need to Speed Up Vaccination Program
The European Union needs to be faster in its efforts to vaccinate people against the coronavirus, the 27 heads of state said on Thursday.
-
Here's What Investors Should Know About Rocket Builder Astra as It Prepares to Go Public
Rocket builder Astra is preparing to go public via a SPAC in the second quarter, with CEO Chris Kemp telling CNBC how the company plans to scale its business.
-
U.S. Should Expedite AstraZeneca Vaccine Authorization Before New Covid Variants Spread, Dr. Peter Hotez Says
Dr. Peter Hotez warned that people should not become complacent due to dropping Covid cases, especially amid reports of B.1.526 spreading in New York.
-
First COVAX Vaccine Shipment Arrives in Ghana as Developing World Hopes to Catch Up
The news is a hopeful turning point for poorer countries that risk being left behind in the global race for vaccinations.
-
Drugmakers Are Ramping Up Covid Vaccine Production After Fixing Initial Manufacturing Delays
“We’ve been in the process of developing a manufacturing process for a vaccine product that we’ve never made before,” Pfizer Chief Business Officer John Young said.
-
UK's Boris Johnson Reveals Plan to Exit Lockdown Restrictions by June
U.K. Prime Minister Boris Johnson on Monday announced his plan for the lifting of lockdown restrictions in England.
-
We're on a ‘One-Way Road to Freedom,' Boris Johnson Tells Britain After Covid Lockdowns
The lockdown easing for England will come in a number of steps and will be data dependent at every stage, the British prime minister said.
-
Watch Live: U.S. Health Officials Join World Health Organization in Covid Briefing for the First Time Since Pandemic Started
The U.S. Food and Drug Administration is expected to authorize Johnson & Johnson’s vaccine in the coming weeks.
-
India's Covid Vaccine Maker Told to Meet Domestic Demand First, Urges ‘Rest of the World' to Be Patient
CEO Adar Poonawalla made the announcement over Twitter but did not explain who gave the direction.
-
India Is Set to Become a Vital COVID Vaccine Maker — Perhaps Second Only to the US
Even before COVID-19, India produced up to about 60% of the world’s vaccines and can do so at a relatively low cost.
-
Stocks Making the Biggest Moves Midday: Disney, Newell Brands, Expedia & More
Check out the companies making headlines in midday trading.
-
Coronavirus Vaccines: Here's What You Need to Know
The rollout of COVID-19 vaccines has been slower and more difficult than Americans had hoped, plagued by an undersupply that the Biden administration is trying to overcome. The new administration announced on Feb. 11 that it had finalized a deal to buy 200 million more doses of the Pfizer BioNTech and Moderna versions of the vaccine, the first to receive…